$4.70
0.05[1.08%]
At close: Apr 17
$4.70
0[0.00%]
After Hours: 7:56PM EDT
Vistagen Therapeutics
(NASDAQ:VTGN)Vistagen Therapeutics Stock (NASDAQ:VTGN), Quotes and News Summary
Vistagen Therapeutics Stock (NASDAQ: VTGN) stock price, news, charts, stock research, profile.
| Open | $4.710 |
| Close | $4.670 |
| Volume / Avg. | 116.230K / 277.922K |
| Day Range | 4.660 - 4.800 |
| 52 Wk Range | 1.620 - 24.710 |
| Market Cap | $127.018M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 7.2% |
| Days to Cover | 3.82 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About VistaGen Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vistagen Therapeutics (VTGN) stock?
You can purchase shares of Vistagen Therapeutics (NASDAQ: VTGN) through any online brokerage.
Who are Vistagen Therapeutics's (VTGN) competitors?
Other companies in Vistagen Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Vistagen Therapeutics (VTGN) stock?
The latest price target for Vistagen Therapeutics (NASDAQ: VTGN) was reported by Jefferies on Thursday, December 7, 2023. The analyst firm set a price target for 15.00 expecting VTGN to rise to within 12 months (a possible 219.15% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Vistagen Therapeutics (VTGN)?
The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $4.7 last updated April 17, 2024 at 7:56 PM EDT.
Does Vistagen Therapeutics (VTGN) pay a dividend?
There are no upcoming dividends for Vistagen Therapeutics.
When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?
Vistagen Therapeutics’s Q4 earnings are confirmed for Wednesday, June 26, 2024.
Is Vistagen Therapeutics (VTGN) going to split?
There is no upcoming split for Vistagen Therapeutics.
What sector and industry does Vistagen Therapeutics (VTGN) operate in?
Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.